Pharos IBio Co (XKRX:388870) Scaled Net Operating Assets : 0.15 (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Pharos IBio Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Pharos IBio Co's operating assets for the quarter that ended in Dec. 2024 was ₩3,960.48 Mil. Pharos IBio Co's operating liabilities for the quarter that ended in Dec. 2024 was ₩891.11 Mil. Pharos IBio Co's Total Assets for the quarter that ended in Sep. 2024 was ₩21,016.56 Mil. Therefore, Pharos IBio Co's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.15.

Pharos IBio Co Scaled Net Operating Assets Historical Data

The historical data trend for Pharos IBio Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharos IBio Co Scaled Net Operating Assets Chart

Pharos IBio Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Scaled Net Operating Assets

Get a 7-Day Free Trial

-5.31

-4.46

0.11

0.17

0.10

Pharos IBio Co Quarterly Data
	Dec19	Dec20	Dec21	Mar22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Scaled Net Operating Assets	Get a 7-Day Free Trial									0.10	0.12	0.13	0.14	0.15

Competitive Comparison of Pharos IBio Co's Scaled Net Operating Assets

For the Biotechnology subindustry, Pharos IBio Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharos IBio Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharos IBio Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Pharos IBio Co's Scaled Net Operating Assets falls into.

Save Embed

;

Save Embed

;

Pharos IBio Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Pharos IBio Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2024 )
=	(Operating Assets (A: Dec. 2024 )	-	Operating Liabilities (A: Dec. 2024 ))	/	Total Assets (A: Dec. 2023 )
=	(3960.481	-	891.106)	/	29690.25
=	0.10

where

	Operating Assets		(A: Dec. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	19628.332	-	15667.851
=	3960.481

	Operating Liabilities		(A: Dec. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1014.822	-	41.608	-	82.108
=	891.106

Pharos IBio Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2024 )
=	(Operating Assets (Q: Dec. 2024 )	-	Operating Liabilities (Q: Dec. 2024 ))	/	Total Assets (Q: Sep. 2024 )
=	(3960.481	-	891.106)	/	21016.561
=	0.15

where

	Operating Assets		(Q: Dec. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	19628.332	-	15667.851
=	3960.481

	Operating Liabilities		(Q: Dec. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1014.822	-	41.608	-	82.108
=	891.106

Pharos IBio Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Pharos IBio Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharos IBio Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharos IBio Co Ltd (XKRX:388870) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

427beon-gil, Dongan-gu, 1407 and 1408, 38, Heungan-daero, Seongji Star With, Gyeonggi-do, Gwanyang-dong, Anyang-si, KOR

Website

https://www.pharosibio.com

Pharos IBio Co Ltd is a company specializing in new drug development that develops treatments for rare and intractable diseases. It utilizes a new drug development platform based on big data and AI technology. Its product candidate comprises PHI-101-AML, a treatment drug for refractory/relapsed acute myeloid leukemia; PHI-101-OC developed for platinum-resistant/refractory ovarian cancer patients; PHI-101-TNBC is being developed as a drug to treat metastatic triple-negative breast cancer (TNBC); PHI-201; PHI-301; and PHI-501.

Pharos IBio Co Headlines

No Headlines